ERAD Therapeutics Inc., an Orphan Disease company focusing on Gaucher Disease and Cystic Fibrosis by delivering protein therapeutics to all cells in the body, including the central nervous system, presented an abstract at the Gordon Research Conference in Galveston, Texas, February 11-18, 2018. The abstract was entitled “Glycosphingolispids provide a basis for the treatment of genetic protein misfolding diseases (e.g. Gaucher disease), antineoplastic therapy and a novel signaling pathway.” The abstract was presented by Dr. Clifford Lingwood, Senior Scientist at the Hospital For Sick Children, Toronto, Canada